NCT01302119

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 604 (actual)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Conditions

• Onychomycosis of Toenails

Interventions

Type	Name	Description
DRUG	AN2690 Topical Solution, 5%	AN2690 Topical Solution, 5%, applied once daily for 48 weeks
DRUG	Solution Vehicle	AN2690 Topical Solution, Vehicle, applied once daily for 48 weeks

Timeline

• Start date: 2011-02-01
• Primary completion: 2012-12-31
• Completion: 2013-02-20
• First posted: 2011-02-23
• Last updated: 2019-04-03
• Results posted: 2014-08-15

Locations

32 sites across 2 countries: United States, Canada